Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors

Eur J Med Chem. 2016 May 23:114:162-9. doi: 10.1016/j.ejmech.2016.02.038. Epub 2016 Feb 23.

Abstract

A novel series of substituted chalcones were designed and synthesized to be evaluated as selective human MAO-B inhibitors. A combination of either methylsulfonyl or trifluoromethyl substituents on the aromatic ketone moiety with a benzodioxol ring on the other end of the chalcone scaffold was investigated. The compounds were tested for their inhibitory activities on both human MAO-A and B. All compounds appeared to be selective MAO-B inhibitors with Ki values in the micromolar to submicromolar range. Molecular modeling studies have been performed to get insight into the binding mode of the synthesized compounds to human MAO-B active site.

Keywords: Chalcones; Drug design; Enzyme; Monoamine oxidase; Neuroprotection; Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chalcones / chemical synthesis*
  • Chalcones / chemistry
  • Chalcones / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / chemical synthesis
  • Monoamine Oxidase Inhibitors / chemistry*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Structure-Activity Relationship

Substances

  • Chalcones
  • Monoamine Oxidase Inhibitors
  • Monoamine Oxidase